Dogecoin Cash, Inc.’s latest quarterly filing confirms the company’s core business remains the PrestoDoctor telemedicine platform which connects patients with licensed physicians for medical cannabis evaluations via video consultations. Though digital asset projects exist as subsidiaries, telemedicine generates virtually all revenues. The asset-light platform model offers scalability but faces competitive pressure from larger players and is highly sensitive to state regulatory changes. Recent blockchain token acquisitions strengthen ancillary digital initiatives but remain non-core. Demand drivers include expanding state legalization and consumer adoption of telehealth regulated cannabis services, while ongoing regulatory uncertainty and physician network compliance pose operational risks.